Clinical Trial Update: TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. [Phase 1]

View source ↗

Summary

A Phase I, open-label trial evaluated the pharmacokinetic interaction between TMC125 (etravirine) and the antifungal agents fluconazole and voriconazole in heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection
• HIV Infection

Drugs mentioned

• Fluconazole (Fluconazole)
• TMC125 (dapivirine)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV, AIDS | Phase 1 | Status: COMPLETED